Valcare Medical

Valcare Medical is dedicated to developing innovative, minimally invasive technologies for treating mitral regurgitation, a heart valve condition. Founded in 2012, the company focuses on advanced transcatheter solutions that cater to patients who may not be suitable for traditional surgery. Their flagship product, the AMEND™ mitral annuloplasty ring, is designed to reshape the mitral annulus and reduce regurgitation. This D-shaped ring also serves as a docking station for future valve replacement technologies, highlighting Valcare's commitment to modular approaches in valve therapy. The company has received FDA approval to begin early feasibility studies for its AMEND™ Trans-Septal System, showcasing its ongoing clinical development. Valcare Medical targets cardiologists, cardiac surgeons, and healthcare institutions specializing in structural heart disease, aiming to improve patient outcomes through less invasive procedures. With a strong management team and a Scientific Advisory Board of mitral valve experts, Valcare is positioned as a leader in valve care technology.

• Employees30
• Founded2012